Exodus Point Capital Management, LP Edwards Lifesciences Corp Transaction History

Exodus Point Capital Management, LP

$9.1 Billion
Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 21,276 shares of EW stock, worth $1.84 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,276

Previous 177,661 88.02%

Holding current value

$1.84 Million

Previous $13.9 Million 88.1%

% of portfolio

0.02%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$73.75 - $81.83 $11.5 Million - $12.8 Million	-156,385 Reduced 88.02%	21,276 $1.65 Million
Q2 2025 Aug 13, 2025	BUY	$67.07 - $78.22 $11.9 Million - $13.9 Million	177,661 New	177,661 $13.9 Million
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $1.96 Million - $2.31 Million	30,428 New	30,428 $2.25 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $9.76 Million - $12.9 Million	134,521 Added 248.07%	188,747 $18 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $3.76 Million - $5.06 Million	54,226 New	54,226 $3.76 Million

Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $9.46 Million - $12.1 Million	-138,438 Reduced 93.41%	9,762 $728,000
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $12.2 Million - $15.9 Million	148,200 New	148,200 $12.2 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $1.28 Million - $1.57 Million	-12,040 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $404,230 - $482,162	3,928 Added 48.42%	12,040 $1.36 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $4.38 Million - $5.47 Million	-52,233 Reduced 86.56%	8,112 $840,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $2.45 Million - $2.83 Million	31,158 Added 106.75%	60,345 $5.05 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.11 Million - $1.48 Million	19,227 Added 193.04%	29,187 $2.02 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $16,404 - $25,353	313 Added 3.24%	9,960 $1.88 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $691,689 - $791,922	9,647 New	9,647 $2.25 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $632,610 - $775,269	-10,278 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1.41 Million - $1.63 Million	-25,275 Reduced 71.09%	10,278 $1.9 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $1.24 Million - $1.66 Million	25,893 Added 268.04%	35,553 $6.8 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $448,320 - $550,040	9,660 New	9,660 $1.48 Million

Others Institutions Holding EW

# of Institutions

1,460

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Edwards Lifesciences Corp Transaction History